Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulations

Details for Australian Patent Application No. 2007202851 (hide)

Owner Dana-Farber Cancer Institute, Inc. Beth Israel Deaconess Medical Center The General Hospital Corporation d/b/a Massachusetts General Hospital

Inventors Wilson, Samuel B; Balk, Steven P; Exley, Mark A

Agent Griffith Hack

Pub. Number AU-B-2007202851

Parent 2001268599

Filing date 19 June 2007

Wipo publication date 12 July 2007

Acceptance publication date 17 February 2011

International Classifications

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 15/00 (2006.01) Drugs for genital or sexual disorders

A61P 15/04 (2006.01) Drugs for genital or sexual disorders

A61P 15/06 (2006.01) Drugs for genital or sexual disorders

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 33/00 (2006.01) Antiparasitic agents

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

A61P 37/04 (2006.01) Drugs for immunological or allergic disorders

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

A61P 37/08 (2006.01) Drugs for immunological or allergic disorders

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 5/071 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Vertebrate cells or tissues, e.g. human cells or tissues

C12N 5/0783 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - T cells

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 5/20 Undifferentiated human, animal or plant cells, e.g. cell lines - one of the fusion partners being a B lymphocyte

Event Publications

5 July 2007 Complete Application Filed

12 July 2007 Application Open to Public Inspection

  Published as AU-B-2007202851

3 February 2011 Assignment before Grant

  Dana-Farber Cancer Institute, Inc.; Beth Israel Deaconess Medical Center The application has been assigned to DanaFarber Cancer Institute, Inc.; The General Hospital Corporation d/ b/a Massachusetts General Hospital; Beth Israel Deaconess Medical Center

17 February 2011 Application Accepted

  Published as AU-B-2007202851

16 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007202852-A Dual-cone Tympanic Loudspeaker

2007202850-Method and apparatus for creating a pulsed stream of particles